Advanced search
Publication Cover
Current Medical Research and Opinion Volume 33, 2017 - Issue 12
Submit an article Journal homepage
1,026
Views
12
CrossRef citations to date
0
Altmetric
Cardiovascular

Safety and effectiveness of tadalafil in pediatric patients with pulmonary arterial hypertension: a sub-group analysis based on Japan post-marketing surveillance

Hiroyoshi YamazakiGlobal Patient Safety Japan, Quality & Patient Safety, Eli Lilly Japan K.K., Kobe, Japan; Correspondence[email protected]
,
Noriko KobayashiPost Marketing Study Management, Medicines Development Unit Japan, Eli Lilly Japan K. K., Kobe, Japan;
,
Masanori TaketsunaStatistical Sciences, Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan;
,
Koyuki TajimaPost Marketing Surveillance Clinical Research Department, Nippon Shinyaku CO., Ltd, Kobe, Japan;
,
Nahoko SuzukiBiometrics, Medicines Development Unit Japan, Eli Lilly Japan K.K., Tokyo, Japan;
&
Masahiro MurakamiMedical Science, Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan
Pages 2241-2249 | Received 29 Mar 2017, Accepted 10 Jul 2017, Published online: 20 Jul 2017

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

F. Rana Olguntürk. (2020) An update on the diagnosis and treatment of pediatric pulmonary hypertension. Expert Opinion on Pharmacotherapy 21:10, pages 1253-1268.
Read now

Articles from other publishers (11)

Jefferson Antonio Buendía, Erika Fernanda Lindarte & Diana Guerrero Patiño. (2023) Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis. Value in Health Regional Issues 36, pages 44-50.
Crossref
Candice D. Fike & Judy L. Aschner. (2023) Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future. Pharmaceuticals 16:4, pages 503.
Crossref
Jiao Li, Jing Zhao, Xiao-Yan Yang, Jing Shi & Hai-Ting Liu. (2022) Successful treatment of pulmonary hypertension in a neonate with bronchopulmonary dysplasia: A case report and literature review. World Journal of Clinical Cases 10:32, pages 11898-11907.
Crossref
Jessica Rehmel, Lisa Ferguson‐Sells, Bridget L. Morse, Baohui Li & Gemma L. Dickinson. (2021) Physiologically based pharmacokinetic modeling of tadalafil to inform pediatric dose selection in children with pulmonary arterial hypertension. CPT: Pharmacometrics & Systems Pharmacology 11:2, pages 173-184.
Crossref
Dunbar Ivy, Damien Bonnet, Rolf Berger, Gisela M.B. Meyer, Simin Baygani & Baohui Li. (2021) Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double‐blind placebo‐controlled study. Pulmonary Circulation 11:3, pages 1-8.
Crossref
Devashis Mukherjee & Girija G. Konduri. 2011. Comprehensive Physiology. Comprehensive Physiology 2135 2190 .
Charissa W. Kam & Fadel E. Ruiz. (2020) Opportunities and challenges of pharmacotherapy for pulmonary arterial hypertension in children. Pediatric Pulmonology 56:3, pages 593-613.
Crossref
Benjamin S. Frank, Asrar Rashid & Dunbar Ivy. 2020. Critical Care of Children with Heart Disease. Critical Care of Children with Heart Disease 465 489 .
David Small, Lisa Ferguson‐Sells, Nagib Dahdah, Damien Bonnet, John Landry & Baohui Li. (2019) Pharmacokinetics and safety of tadalafil in a paediatric population with pulmonary arterial hypertension: A multiple ascending‐dose study. British Journal of Clinical Pharmacology 85:10, pages 2302-2309.
Crossref
Maurice Beghetti, Matthias Gorenflo, D. Dunbar Ivy, Shahin Moledina & Damien Bonnet. (2019) Treatment of pediatric pulmonary arterial hypertension: A focus on the NO‐sGC‐cGMP pathway. Pediatric Pulmonology 54:10, pages 1516-1526.
Crossref
J.A. Jaffey, S.B. Leach, L.R. Kong, K.E. Wiggen, S.B. Bender & C.R. Reinero. (2019) Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study. Journal of Veterinary Cardiology 24, pages 7-19.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.